Skip to content

Menu

DLA Piper logo
DLA Piper logo
HomeAboutContact
Search
Close

Israel Global Gateway

Connecting Israel to the World

regulations

Subscribe to regulations via RSS

US Supreme Court round-up: Business impacts for in-house counsel to know

By Yael Bailey on July 28, 2024
Posted in Uncategorized


During its 2023–2024 term, the US Supreme Court issued a number of rulings with major implications for businesses, especially those in regulated industries.

The Court’s decision in Loper Bright Enterprises v. Raimondo, decisively overruling…

Continue Reading US Supreme Court round-up: Business impacts for in-house counsel to know
Centrifuge_S_0292

Guest Blog: FDA aims for international harmonization and modernized clinical trials

By Israel Group on August 2, 2023
Posted in Uncategorized

Written by: Bethany Hills, Adam Donat

The Food and Drug Administration (FDA) has released a draft guidance titled, “Good Clinical Practice (GCP) E6(R3),” explaining how the Agency plans to apply its regulations…

Continue Reading Guest Blog: FDA aims for international harmonization and modernized clinical trials

About

Israel Global Gateway is a blog about business and legal issues important to Israeli companies, investors and entrepreneurs in support of their global activities. Israel Global Gateway is edited by Jeremy Lustman, head of DLA Piper’s Israel Country Group.

Topics

Archives

Subscribe by Email

Stay Connected

RSS Twitter LinkedIn Facebook YouTube Instagram WeChat

Legal Notices | Privacy Policy | Cookie Policy | dlapiper.com

RSS Twitter LinkedIn Facebook YouTube Instagram WeChat
Copyright © 2025, DLA Piper. DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper’s structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.
Law blog design & platform by LexBlog LexBlog Logo